Awarded

trivalenter Influenza-Impfstoff ab 60 Jahren (hochdosiert oder adjuvantiert)

Contract value
€117,758
Bids received
3
Published
23 Apr 2026
Awarded
20 Apr 2026
Contract start
15 Jun 2026
Contract end
30 Apr 2027stated

More awards from this buyer